Fried Frank Reps Merck In $430M Inspire Deal

Law360, New York (April 5, 2011, 1:22 PM EDT) -- Merck & Co. Inc. on Tuesday announced plans to acquire North Carolina-based Inspire Pharmaceuticals Inc. for roughly $430 million, expanding its ophthalmology business and promising emerging treatments for eye diseases.

Under the terms of agreement, Merck is offering to buy all of Inspire’s outstanding common stock at $5 per share, a 26 percent premium to the closing price on Monday, giving the deal a total cash value of $430 million, according to the press release.

The boards of directors of both companies have wholeheartedly approved the...
To view the full article, register now.